Sleep Medicine Compliance: AASM Accreditation + CMS Documentation

Sleep medicine practices operate under the CMS National Coverage Determinations for OSA diagnosis and CPAP therapy (NCD 240.4 and 240.4.1), MAC-published LCDs for polysomnography and HSAT, AASM accreditation as the de-facto industry standard, DMEPOS Supplier Standards at 42 CFR § 424.57 for any PAP-supply business, and state polysomnographic technologist licensure where it exists. Audit exposure clusters around documentation linking the sleep study, the therapy decision, the device delivery, and the ongoing adherence.

What CMS actually requires for a sleep medicine practice

CMS coverage for OSA diagnosis lives at NCD 240.4.1 for the use of HSAT and at NCD 240.4 for CPAP coverage in OSA. The NCDs define the patient eligibility criteria, the testing modality framework, and the therapy threshold. MACs publish LCDs operationalizing the NCDs with specific documentation expectations.

For diagnosis, HSAT (CPT 95800, 95801, 95806) is covered for patients with a high pre-test probability of moderate to severe OSA who do not have suspected alternative sleep diagnoses (central sleep apnea, narcolepsy, periodic limb movement disorder, parasomnia). Polysomnography (CPT 95810, 95811) is required when the differential includes non-OSA diagnoses or when HSAT is non-diagnostic or technically inadequate.

For CPAP/BiPAP coverage, NCD 240.4 requires:

• Diagnosis of OSA with AHI ≥ 15 (or AHI 5-14 with documented symptoms or comorbidities)
• Face-to-face clinical evaluation by the treating practitioner before the sleep study
• Sleep study result documented
• Initial 12-week therapy trial period
• In-person re-evaluation between 31 and 91 days of therapy initiation
• Adherence documentation: ≥ 4 hours per night on ≥ 70% of nights during a 30-consecutive-day period within the first three months
• Clinical benefit documented at the in-person follow-up

Continued coverage past the 12-week trial period depends on the adherence and benefit documentation. Documentary failure terminates coverage; the supplier and the prescribing physician each carry pieces of the documentation burden.

DMEPOS Supplier Standards at 42 CFR § 424.57 apply to any PAP-supply business — the device itself, masks, tubing, filters, humidifier chambers. Accreditation through a CMS-approved deemed accreditor and a $50,000 surety bond are the default supplier requirements. The 30 Supplier Standards apply. Eligible-professional exemptions (CMS MLN905710 for accreditation, 42 CFR § 424.57(d)(15)(i)(C) for the surety bond when furnishing only to own patients as part of a service) can apply where a sleep physician personally dispenses PAP devices to their own patients as part of the encounter, but a standalone PAP-supply business that fills prescriptions from other providers does not meet the "own patients as part of the service" condition and the defaults apply in full.

AASM accreditation is not a federal requirement but is the recognized industry standard. AASM accreditation requires sleep center medical director credentialing, RPSGT-credentialed technologists, specific patient-flow and study-documentation standards, and a quality-improvement program.

State polysomnographic technologist licensure applies in several states. Florida, Tennessee, Louisiana, Texas, and others operate licensure schemes; California operates a credentialing requirement under specific facility licensure rules. State licensure typically requires examination, continuing education, and renewal.

Stark physician self-referral at 42 CFR § 411 applies when the sleep medicine practice owns its own PAP-supply business or distributes PAP devices to its own patients. The in-office ancillary services exception elements must be met.

The documents you must maintain

A sleep medicine compliance binder should produce on demand:

• AASM accreditation certificate (if accredited), with reaccreditation cycle planning at 180 days
• AASM medical director designation and credentialing file (board certification in sleep medicine or training-equivalent)
• RPSGT credentialing files for every sleep technologist
• State polysomnographic technologist license tracker for every technologist
• Sleep study request template aligned with the LCD and NCD criteria (face-to-face evaluation, AHI threshold, differential diagnosis)
• HSAT vs polysomnography modality decision documentation
• Sleep study interpretation template with the physician interpretation requirement met
• CPAP/BiPAP prescription template aligned with NCD 240.4
• 12-week trial period in-person follow-up visit documentation between days 31 and 91
• Therapy adherence documentation: downloaded device data showing 4-hours/70%-of-nights pattern
• Clinical benefit documentation at the follow-up visit referencing the adherence data
• DMEPOS supplier-number tracker and the $50,000 surety bond (if the practice operates the PAP-supply business)
• DMEPOS accreditation certificate (if applicable)
• Proof-of-delivery files for every dispensed PAP device, mask, and supply item
• Prescription renewal tracker tied to the supply-resupply intervals per HCPCS code
• Modifier KX documentation for PAP supplies asserting LCD criteria are met
• Stark in-office ancillary services exception self-attestation for in-office PAP-supply business
• HIPAA risk analysis covering the EHR, the sleep-lab data system, and the DMEPOS billing system
• Patient consent for the sleep study with documented modality discussion
• Equipment QA and calibration logs for every PSG monitoring channel
• Infection-control program for in-lab studies (cleaning of headboxes, masks, and reusable sensors)
• BAA file for any third-party scoring service, telemedicine vendor, or DMEPOS billing service

In sleep medicine audits we have responded to, the most common LCD documentation finding is the face-to-face clinical evaluation that precedes the sleep study. The chart contains a problem-focused note that documents the symptoms but does not document the specific differential diagnosis the sleep study is intended to address.

How audits actually work in sleep medicine

MAC TPE audits in sleep medicine target both the sleep study and the PAP supplies. For the sleep study, the audit examines:

1. Face-to-face evaluation before the study. The CMS NCD and MAC LCDs require it; the chart needs the documented encounter.
2. HSAT vs polysomnography modality justification. Documentation must support the modality chosen given the working differential.
3. Interpretation by a physician meeting the LCD's qualification standard. Board certification in sleep medicine or training-equivalent.
4. Repeat sleep study justification. LCDs typically require new symptoms, treatment failure, or significant clinical change to justify a repeat.

For PAP supplies, the audit examines:

1. Initial polysomnography or HSAT supporting the AHI threshold.
2. In-person follow-up visit between days 31 and 91.
3. Therapy adherence documentation (downloaded device data).
4. Clinical benefit documentation at the follow-up.
5. Proof of delivery for every supply item.
6. Prescription renewal at the appropriate intervals.
7. Modifier KX attestation supported by the documentation.

RAC audits commonly target PAP supplies with extrapolation risk. A finding of 30% adherence documentation gaps on a sample of 30 claims can extrapolate to the universe of claims for the period — a material recovery.

UPIC audits in sleep medicine often examine self-referral patterns. The pattern: sleep medicine practice owns the PAP-supply business and refers nearly all PAP patients to its in-house DMEPOS supplier with documentation gaps in the Stark in-office ancillary services exception elements.

AASM reaccreditation surveys examine the medical director credentialing, the technologist credentialing, the patient-flow and documentation standards, the QI program, and the equipment QA. Findings can trigger conditional accreditation or denial.

What sleep medicine practices most often miss is the linkage documentation between the sleep study and the device delivery. The study is in the chart, the device is dispensed, but the chart does not explicitly reference the AHI value, the modality used, or the LCD threshold met. The MAC reads the audit as if the documents are disconnected.

Common gaps unique to sleep medicine

• HSAT performed when the differential included central sleep apnea or other non-OSA diagnoses.
• Face-to-face evaluation by a different provider than the one whose name appears on the sleep study order.
• Sleep study interpretation by a physician not meeting the LCD's qualification standard.
• Therapy adherence documentation gap during the 12-week trial period. Device data show < 4 hours per night or < 70% of nights and the practice continued billing.
• In-person follow-up visit performed outside the 31-91 day window.
• Proof-of-delivery dated before the visit or signed by someone other than the patient.
• DMEPOS supplier number missing or expired when PAP supplies are billed.
• Modifier KX asserted without the underlying LCD documentation.
• Sleep technologist operating outside the state polysomnographic technologist license (where applicable).
• AASM accreditation lapsed and not disclosed to commercial payers that require it.
• Repeat sleep study without documented justification (new symptoms, treatment failure, significant change).

Maintenance cadence

• Daily: Equipment QA pre-study check; controlled-substance reconciliation if any procedural sedation is used; PAP-supply order completeness check
• Weekly: Sleep study scoring quality review; PAP-supply proof-of-delivery sample audit
• Monthly: LCD documentation audit (sample of 20 sleep studies for face-to-face evaluation, modality justification, and interpretation); adherence documentation sample for PAP patients
• Quarterly: AASM accreditation standards self-assessment; Stark in-office ancillary services exception self-attestation (for in-office PAP-supply business); RPSGT and state license review for every technologist
• Annually: AASM reaccreditation planning at 180 days; DMEPOS supplier-number revalidation and accreditation renewal; HIPAA risk analysis; MIPS measure selection where applicable; sleep lab equipment full QA
• At every staff onboard: RPSGT credential verification; state polysomnographic technologist license verification (where applicable); HIPAA training; PAP-device usage training

State preemption to watch

California — CDPH facility licensure for sleep centers under specific provisions; California Title 22 requirements for clinical laboratory and certain outpatient settings; CMIA layered on every disclosure; mandatory CURES query for any controlled-substance use in procedural sedation.

Texas — Texas polysomnographic technologist licensure under Occupations Code Chapter 605; DSHS facility licensure where applicable; HB 300 layered.

New York — Article 28 DOH licensure for some sleep centers; specific polysomnographic technologist credentialing requirements through state Department of Education.

Florida — Florida polysomnographic technologist licensure under F.S. Chapter 468; Bureau of Radiation Control rules where any imaging is used; AHCA facility licensure for some sleep centers; pain-clinic registration considerations if the practice prescribes controlled substances for sleep-related diagnoses.

How d3rx fits

The d3rx specialty compliance binder maintains the sleep medicine module: AASM accreditation tracker, RPSGT and state-license tracker per technologist, sleep study request template aligned with the LCD and NCD criteria, HSAT vs polysomnography modality decision documentation, the 12-week PAP trial documentation set, therapy adherence documentation workflow, DMEPOS supplier-number and accreditation tracker, the Stark in-office ancillary services exception self-attestation, and the proof-of-delivery and modifier KX documentation set. It is a source-grounded administrative documentation aid. See the compliance binder overview or the audit defense surface for how the sleep medicine module integrates with the broader binder.

D3rx compliance guides are administrative documentation aids. They do not certify compliance, provide legal advice, replace counsel, or guarantee an audit outcome. The practice remains responsible for reviewing, adopting, and maintaining its compliance program.